Abbott

AbbottAt Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

www.abbott.com

Abbott RSS Channel

Display # 
Title Published Date
What's the secret to living a full life? A new global survey reveals family comes first 27 April 2016
Abbott's Absorb, the first fully dissolving heart stent, earns positive review by FDA advisory committee 17 March 2016
Abbott to Acquire Alere, becoming leader in point of care testing 01 February 2016
Abbott and UC San Francisco discover new virus is linked to hepatitis C 14 December 2015
'Science' says Abbott is a Top Employer 30 October 2015
Abbott is asking one million people worldwide. Here's why and how. 22 September 2015
Abbott named industry leader for responsible and sustainable business for three consecutive years on the Dow Jones Sustainability Index (DJSI) 11 September 2015
Abbott completes acquisition of Veropharm 12 December 2014
Abbott to sell its developed markets branded generics pharmaceuticals business to Mylan 14 July 2014
Abbott to acquire Veropharm 23 June 2014
Abbott enhances its position in fast-growing Latin American market 18 May 2014
Abbott reports first-quarter 2014 results 16 April 2014
Abbott completes enrollment of Absorb™ randomized clinical trials in the United States, Japan and China 10 April 2014
Abbott reports fourth-quarter and full-year 2013 results 22 January 2014
Experience a day in the life of an insulin-using patient with diabetes through interactive infographic 14 November 2013
Abbott reports third-quarter 2013 results 16 October 2013
Abbott reports first-quarter 2013 results 17 April 2013
Abbott to collaborate with Janssen and Pharmacyclics 21 February 2013
Abbott initiates clinical trial of Absorb TM in the United States 08 January 2013
Abbott completes separation of research-based pharmaceuticals business 02 January 2013

Most Popular Now

World's first public dengue immuniz…

Sanofi and its vaccines global business unit Sanofi Pasteur announced today that the first public dengue immunization program has started in the Philippines. At a major l...

Read more

NIH launches large clinical trials …

Enrollment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection. Known as the A...

Read more

AstraZeneca and Eli Lilly and Compa…

AstraZeneca and Eli Lilly and Company today announced that AMARANTH, a Phase II/III study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in...

Read more

Saxenda® demonstrated significant i…

Today, new data from the three-year part of the phase 3a SCALE™ (Satiety and Clinical Adiposity - Liraglutide Evidence) Obesity and Prediabetes trial were presented at th...

Read more

Vitamin D improves heart function, …

A daily dose of vitamin D3 improves heart function in people with chronic heart failure, a five-year University of Leeds research project has found. Dr Klaus Witte, from ...

Read more

Pfizer announces termination of pro…

Pfizer Inc. (NYSE: PFE) announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. The deci...

Read more

New analysis shows only minority of…

Boehringer Ingelheim has announced a new publication showing that levels of white blood cells called eosinophils can help identify patients with COPD who may and may not ...

Read more

Researchers open the way to new tre…

In a recent paper published in Nature Communications, a group of Case Western University School of Medicine researchers presented their discovery of the full-length struc...

Read more

Implantable device targets pancreat…

Pancreatic cancer is the third leading cause of cancer deaths in the United States, in part because it is very difficult for chemotherapy drugs to reach the pancreas, whi...

Read more

Physicians' knowledge about FDA app…

Since 2012, the FDA can designate a drug as a "breakthrough therapy" if preliminary clinical evidence - such as an improvement in a pharmacodynamic biomarker - suggests a...

Read more

Global spending on health is expect…

Global inequities in health spending are expected to persist and intensify over the next 25 years, according to a new study that estimates total health financing in count...

Read more

Americans live longer but with disa…

Americans are living longer but in poorer health, according to a new study. The USC-led study examined life expectancy trends and disability rates in a 40-year period, fr...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]